#EMEA Liquid Biopsy Market Share
Explore tagged Tumblr posts
futuretonext · 1 year ago
Text
The EMEA Liquid Biopsy Market is projected to grow at a CAGR of around 13.98% during the forecast period, 2023-28. The market noticed consistent growth since the past few years, owing to the increasing prevalence of cancer patients coupled with a surge in demand for minimally invasive & fast diagnostic tests for detection. The rising prevalence of cancer has affected patients in the EMEA region, owing to the sedentary lifestyle, harmful carcinogenic elements in the environment, etc. According to the World Health Organisation (WHO), there were around 4 million cancer cases in Europe in 2020, of which nearly 2.4 million cases were in men & over 2.1 million in women.
0 notes
healthcaremarketfmi · 1 year ago
Text
Cancer Biopsy Market Size, Share Production & Consumption Analysis With Forecast To 2033
The Cancer Biopsy market revenues were estimated at US$ 22.2 Bn in 2022 and is anticipated to grow at a CAGR of 18% from 2023 to 2033, according to a recently published Future Market Insights report. By the end of 2033, the market is expected to reach US$ 131.4 Bn.
The increasing elderly populace, along with the rise in instances of cancer diagnoses, is fueling growth in the cancer clinical market. Also, the effective and less costly use of liquid biopsy procedures and increasing biopsy appointees are all expected to impact the market growth.
Some of today’s prominent procedures in medical diagnosis include endoscopic, arthroscopic, bone marrow, skin, needle, and surgical biopsies. Needle biopsies are regarded as a trusted method for the early detection of patients suffering from these methods. However, fine-needle aspiration needle biopsies, which have been found to be less invasive and faster, are aiding the increase in popularity of the slice.
The IARC estimates that by 2020 the worldwide burden of disease due to cancer is projected to be 19.3 million cases and 9.96 million deaths worldwide. A liquid biopsy entails reduced expense, earlier prognosis, therapy surveillance, identification of tumor heterogeneity, acquired drug resistance, and patient comfort compared to conventional diagnostic tools for handling cancer.
Competitive Analysis
Key companies are helping to drive market expansion by diversifying their diagnostics portfolios and increasing the adoption of their own biopsy tools.
Key recent developments of key players in the Cancer Biopsy Market are as follows:
In March 2021, in Russia, KIllumina, Inc. received medical device approval for their NextSeq 550Dx platform and related reagent kits. Prior to this registration, the MiSeq Dx had already been approved as a medical device.
In March 2021, Autopsy with Quick-Core IZI Medical Products introduced a system for soft tissue biopsy procedures. This fully automated product is based on Quick-Core, the company’s patented semi-automatic method.
For More Information :https://www.futuremarketinsights.com/reports/cancer-biopsy-market
Competitive Landscape
Key companies are helping to drive market expansion by diversifying their diagnostics portfolios and increasing the adoption of their own biopsy tools.
In March 2021, In Russia, KIllumina, Inc. has received medical device approval for their NextSeq 550Dx platform and related reagent kits. Prior to this registration, the MiSeq Dx had already been approved as a medical device.
In March 2021, Autopsy with a Quick-Core IZI Medical Products has introduced a system for soft tissue biopsy procedures. This fully automated product is based on Quick-Core, the company’s patented semi-automatic method.
In April 2021, Plasma-SeqSensei liquid biopsy research use only (RUO) kits were introduced in EMEA by Sysmex Europe GmbH and Sysmex Inostics GmbH.
More Insights Available
Future Market Insights, in its new offering, presents an unbiased analysis of the Cancer Biopsy Market, presenting historical market data (2018-2022) and forecast statistics for the period of 2023-2033.
The study reveals essential insights on the basis of by Type (Tissue Biopsies, Liquid biopsies, Other Types), by Product Type (Instruments, Kits and Consumables, Services), by Application (Breast Cancer, Colorectal Cancer, Cervical Cancers, Lung Cancers, Prostate Cancers, Skin Cancers, Blood Cancers, Kidney Cancers, Liver Cancers, Pancreatic Cancers, Ovarian Cancers, Other Applications) across five regions (North America, Latin America, Europe, Asia Pacific and Middle East & Africa).
0 notes
blogwiseguy123world · 4 years ago
Text
Global In Vitro Diagnostics (IVD) Market Analysis, Historic Data and forecast 2014 - 2020
Summary – A new market study, titled "Global In Vitro Diagnostics (IVD) Market: Drivers, Opportunities, Trends and Forecasts: 2014 - 2020" has been featured on WiseGuyReports.
Global In-Vitro Diagnostics Market – Drivers, Opportunities, Trends, and Forecasts: 2017–2023
Overview:
In-vitro diagnostics is a process of diagnosing various medical conditions using assay kits and analyzers. The in-vitro diagnostics (IVD) market is growing at a steady rate as there is an increase in the awareness of various diseases and various plans are initiated by the government to reduce the diseases. Most of the IVD tests are performed in medical and clinical laboratories but the advent of point-of-care (POC) technology has enabled testing to be performed in the presence of the patient and even at their home. This technology advancement is driving market growth during the forecast period.
Also read – https://icrowdnewswire.com/2020/08/05/in-vitro-diagnostics-ivd-market-global-industry-analysis-size-share-growth-trends-forecasts-2025/
Factors, such as increasing lifestyle diseases, growing adoption of POC testing, increasing demand for biomarker-based testing and demand from the emerging countries are expected to drive the market growth during the forecast period. The increased sales of counterfeit glucose monitoring strips and stringent regulatory approval processes are factors hampering the market growth.
The regulatory scenario is of concern as there has been a wide range of instruments and assays, which range from Class I to Class III devices. Recently there has been a change in regulations in the European region, which has been a major issue for the market players.
The market is witnessing an emerging trend for noninvasive prenatal testing, next-generation sequencing (NGS), liquid biopsy, and circulating tumor cells test. The markets in India, Brazil, and China are expected to grow at a rapid pace during the forecast period due to the high prevalence of infectious diseases in these countries.
Market Analysis:
The global in-vitro diagnostics market is estimated to witness a CAGR of 5.31% during the forecast period 2017–2023. The market is analyzed based on five segments – technology, application, test types, end-users, and regions.
Factors, such as increased sales of POC cardiac markers and increased adoption of DNA probe-based diagnostics are growth opportunities for the market players. The market is witnessing an emerging trend of companion diagnostics, cardiac biomarkers, POC markers, and other novel technologies that are helping in diagnosing the diseases at an early stage with precision. There has been a transition from diagnosis in core laboratories to diagnosis in front of the patient.
Regional Analysis:
The regions covered in the in-vitro diagnostics market report are the Americas, EMEA, APAC, and Rest of the World (ROW). The Americas is set to be the leading region for the IVD market growth followed by Europe. Asia Pacific and ROW are set to be the emerging regions. The markets in India, Brazil, and China are expected to grow at a rapid pace during the forecast period as the prevalence of infectious diseases and lifestyle diseases in these countries is high. These countries are set to be the target regions for the market players due to the large untapped potential.
Technology Analysis:
The global IVD market is segmented by the following technologies- immunoassay, clinical chemistry, clinical microbiology, molecular diagnostics, hematology, and coagulation. The clinical chemistry market is currently leading the market with a share of 32.2% due to the high prevalence of diabetes. India has the highest rate of diabetes, making Asia Pacific the region for future investments. The molecular diagnostics segment is expected to have the fastest growth rate during the forecast period. Technological advancements in various molecular diagnostics technology, such as PCR and NGS, are driving the market. The market is also witnessing various M&A and collaborations among the top players, which are defining the future of the global IVD market.
Test Types Analysis:
Core laboratory holds the major share of the market but the advantages of POC technology are expected to make it the fastest growing test type.
Application Analysis:
Among the various diagnostic areas, infectious diseases hold the major share of the market followed by diabetes. But the increasing prevalence of cancer is expected to make it the fastest growing segment.
Key Players:
The leader in IVD market is F. Hoffmann-La Roche, who is currently occupying 20% of the IVD market. Abbott, Siemens, Danaher, and ThermoFisher are the other major players in the market. These top players occupy around 56% of the market. The report covers the following players:
• F. Hoffmann-La Roche
• ThermoFisher Scientific
• Danaher
• Siemens Healthineers
• Abbott
• Sysmex Corporation
• Ortho Clinical Diagnostics
• Bio-Rad Laboratories
• BioMeriux
• Becton Dickenson & Company
Competitive Analysis:
The clinical chemistry segment is dominating the global IVD market, and a lot of new players are focusing on developing technologically advanced reagents and analyzers to gain market share. Novel technologies, such as prenatal testing, liquid biopsy, and cardiac biomarkers, are expected to drive the market growth in the future.
Large players, such as F. Hoffmann-La Roche, Danaher, and Abbott, are acquiring companies with products that would complement their existing portfolio. For instance, in November 2016, Danaher acquired Cepheid and in February 2016, Abbott signed an agreement to acquire Alere, a leader in POC technology. Furthermore, most of the companies are aiming to obtain a waiver of the Clinical Laboratory Improvement Amendments of 1988 for their products to increase their sales. Significant investments in R&D in this market is expected to increase, and collaborations and M&A are expected to continue.
Benefits:
The report provides complete details about the usage and the adoption rate of IVD by various end-users and regions. The key stakeholders use this information to know about the major trends, drivers, investments, vertical player’s initiatives, and government initiatives towards increasing disease awareness, along with the details of commercial devices available in the market. Moreover, the report provides details about the major challenges that are going to impact the market growth. Additionally, the report gives complete details about business opportunities to key stakeholders to expand their business and increase revenue in the specific vertical and to analyze before investing or expanding business in this market.
Key Stakeholders
For more details - https://www.wiseguyreports.com/reports/1568675-global-in-vitro-diagnostics-ivd-market-drivers-opportunities-trends-and-forecasts
About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.              
Contact Us:
NORAH TRENT                                                      
Ph: +162-825-80070 (US)                        
Ph: +44 2035002763 (UK)      
0 notes
market-research-future · 4 years ago
Text
Needle Biopsy Market Trends, Insights, Outlook and Applications
Needle Biopsy Market Share, Growth And Trends Analysis By Type (Fine-Needle Aspiration Biopsy, Core Needle Biopsy, Vacuum-Assisted Biopsy, Image-Guided Biopsy) By Utility (Disposable, Reusable), By Applications (Tumor, Infection, Inflammation, Others) - Global Forecast Till 2023
Needle Biopsy Market Segmentation:
The global needle biopsy market is segmented based on type and applications. Based on type, the market has been segmented as fine-needle aspiration biopsy, core needle biopsy, vacuum-assisted biopsy and image-guided biopsy. Based on the utility, the market has been segmented as disposable and reusable. Based on the applications, the Needle Biopsy Market Trends has been segmented as tumor, infection, inflammation and others.
Global Needle biopsy Market Players:
Key players profiled in the report are Boston Scientific Corporation, Cook Medical, CareFusion Corporation, Hologic, Inc., and Cardinal Health, Inc., Medax, C. R. Bard, Inc., Möller Medical GmbH, Becton, Dickinson and Company, Hakko co. ltd., Kompass, Argon Medical Devices, Inc. and others.
Needle Biopsy Market Highlights
The growing stringent regulation and standards for medical devices, and the increasing uncertainty about reimbursement in the US are threatening the growth of the market.
Request Free sample Copy at: https://www.marketresearchfuture.com/sample_request/3830
Increasing automation will enhance the capabilities of needle biopsy and it may substitute the needle biopsy procedures. Real time progression of cancers is also possible in needle biopsy which raises the level of threat it possesses to needle biopsy. The falling cost of products due to greater market fragmentation and the emergence of Chinese companies is expected to put additional pressures on prices.
In our estimates vacuum assisted needle biopsy will be the fastest growing segment. The increasing screening rates for cancers through the world will stimulate the market. Among the various cancers, breast cancer is expected to generate the largest use of needle biopsy. Needle Based Biopsy Guns is another lucrative strategy that is being pursued by many players. Core needle biopsy has a higher efficiency and detectability rate than fine needle aspiration biopsy. There is increasing bias to use core needle biopsy in combination with needle aspiration biopsy to achieve highest sensitivity and detectability. Thus, the two tests are complementary, and the effectiveness rate is highest with both tests are done together.
The global needle biopsy market is growing at a rate of 5.2 % and is expected show a similar trend during the forecast period. The needle biopsy market is chiefly driven by product development and the fall in prices of raw materials and components. The emergence of needle biopsy is estimated to pose the greatest threat to the biopsy needle market. Needle biopsy offers non-invasive diagnostic tests for detecting cancer as it used liquids such as blood, urine, saliva etc. to detect malignancy.
The increasing cases of cancers and growing usage of biopsy needles is driving the market. Companies should focus on improving the distribution efficiency so as to reduce the pressures on prices due to huge market fragmentation. Distributional agreements between large players and advanced products such as multilayer needles will be extremely beneficial.
Brows More Healthcare Related Research Reports
Image Guided Radiotherapy Market Size, Trends | Share Analysis, 2023
Central Pontine Myelinolysis Market Research Report- Forecast to 2023 | MRFR
EMEA Beauty Devices Market Size, Trends | Share Analysis, 2021
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team has supreme objectives to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Akash Anand,
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
0 notes
atomicjellyfishdelusion · 5 years ago
Text
Worldwide Molecular Diagnostics Market to Witness over X.X% Growth 'in Revenue During the COVID-19 Pandemic
This market research report includes a detailed segmentation of the global molecular diagnostics market by application (oncology, blood testing, infectious disease, genetic testing, and tissue typing), by technology type (PCR, INAAT, Microarray, Hybridization, DNA Sequencing and other MDX technology), by end-users (hospitals, reference laboratories and others), and by regions (Americas, APAC, EMEA, and RoW). The market research report identifies F.Hoffmann-La Roche, Abbott Diagnostics, Siemens Healthineers, Danaher, and Hologic as the major vendors operating in the global molecular diagnostics market.
Request For Report Sample@ https://www.trendsmarketresearch.com/report/sample/10454
Overview of the Global Molecular Diagnostics Market Research
Infoholic’s market research report predicts that the global molecular diagnostics market will grow at a CAGR of 8.7% during the forecast period. The market for molecular diagnostics is driven by increasing prevalence of infectious and other lifestyle diseases, increasing demand for non-invasive biomarker-based tests, growing adoption of point-of-care testing, and high growth of the market in emerging countries. Increasing number of mergers & acquisitions and growing significance of companion diagnostics are providing opportunities for the market growth. Low awareness about standardization, stringent regulatory approval process, and lack of skilled labors are hampering the market growth.
According to the molecular diagnostics industry analysis, North America accounted for the largest share of the global molecular diagnostics market in 2017. The reason for the market’s growth in the Americas is the increasing incidences of disease and organ transplantation in the US along with increasing funding by government and private players and increased adoption of personalized medicine in clinical practices are some of the factors driving the molecular diagnostics market growth. The Asia Pacific region is expected to witness the fastest growth rate due to the large patient pool, increasing awareness, and rising healthcare expenditure.
Get Complete TOC with Tables and Figures@ https://www.trendsmarketresearch.com/report/discount/10454
Molecular Diagnostics Market Research competitive analysis and key vendors Molecular diagnostics are performed mainly to examine the existence of the disease in blood, tissue, or even in bones. The importance of nucleic acids and other cellular biomarkers in defining the vital cellular process has facilitated medical advancements in the diagnosis of various diseases. Early diagnosis of the disease is one of the key advantages of this technology. The capacity of molecular diagnostics to systematize molecular reactions for the enhancement of the clinical diagnosis has put healthcare in the front line. The increasing importance of molecular diagnostic tests has resulted in the launch of new tests and also increased acquisition, strategic partnership, and funding to develop new tests and technologies. For instance, in April 2018, NanoString Technologies, Inc. launched a Breast Cancer 360 (BC 360) research panel. In July 2017, MDxHealth SA announced the commercial launch of its AssureMDx for bladder cancer test in the US as a laboratory developed test. Illumina recently started a new company, named GRAIL, for liquid biopsy. It invested $100 million and raised another $900 million through public funding to develop new non-invasive tests for cancer diagnosis.
Some of the Key Vendors in the Molecular Diagnostics Market Research are:
Hoffmann-La Roche
Abbott Diagnostics
Siemens Healthineers
Danaher
Hologic
Molecular Diagnostics Market Research by Application type
Oncology
Blood Testing
Infectious Disease
Genetic Testing
Tissue Typing
In 2017, the infectious disease application occupied the largest share due to large number of patients suffering from hospital-associated infection, sexually transmitted infection (STI), hepatitis, respiratory infection, pathogen ID detection, and others is fostering the market growth, but oncology is expected to grow at the highest growth rate during the forecast period due to increasing incidence of cancer globally.
Molecular Diagnostics Market Research By Technology
PCR
INAAT
Microarray
Hybridization
DNA Sequencing
Other MDX Technology
In 2017, the PCR segment occupied the largest share. PCR is a gold standard technique for DNA amplification and is the primary technique conducted prior to any molecular diagnostic examination Next-generation sequencing and microarray are expected to grow at the fastest rate during the forecast period.
Molecular Diagnostics Market Research By End-Users
Hospitals
Reference Laboratories
Others
In 2017, the hospitals occupied the largest share and is expected to continue the same trend during the forecast period.
Molecular Diagnostics Market Research Benefits
The report provides detailed information about the usage and adoption of molecular diagnostics market in various applications and regions. With that, key stakeholders can find out the major trends, drivers, investments, vertical player’s initiatives, government initiatives toward the product adoption in the upcoming years, along with the details of commercial products available in the market. Moreover, the report provides details about the major challenges that are going to have an impact on market growth. Additionally, the report gives complete details about the business opportunities to key stakeholders to expand their business and capture revenues in the specific verticals. The report will help companies interested or established in this market to analyze the various aspects of this domain before investing or expanding their business in the molecular diagnostics market.
Key Stakeholders:
<<< Get COVID-19 Report Analysis >>> https://www.trendsmarketresearch.com/report/covid-19-analysis/10454
0 notes
futuretonext · 1 year ago
Text
The EMEA Liquid Biopsy Market is projected to grow at a CAGR of around 13.98% during the forecast period, 2023-28. The market noticed consistent growth since the past few years, owing to the increasing prevalence of cancer patients coupled with a surge in demand for minimally invasive & fast diagnostic tests for detection. The rising prevalence of cancer has affected patients in the EMEA region, owing to the sedentary lifestyle, harmful carcinogenic elements in the environment, etc. According to the World Health Organisation (WHO), there were around 4 million cancer cases in Europe in 2020, of which nearly 2.4 million cases were in men & over 2.1 million in women.
0 notes
market-research-future · 4 years ago
Text
Needle Biopsy Market Segmentation, Dynamics Till 2023
Needle Biopsy Market Share, Growth And Trends Analysis By Type (Fine-Needle Aspiration Biopsy, Core Needle Biopsy, Vacuum-Assisted Biopsy, Image-Guided Biopsy) By Utility (Disposable, Reusable), By Applications (Tumor, Infection, Inflammation, Others) - Global Forecast Till 2023
Needle Biopsy Market Segmentation:
The global needle biopsy market is segmented based on type and applications. Based on type, the market has been segmented as fine-needle aspiration biopsy, core needle biopsy, vacuum-assisted biopsy and image-guided biopsy. Based on the utility, the market has been segmented as disposable and reusable. Based on the applications, the needle biopsy market has been segmented as tumor, infection, inflammation and others.
Needle Biopsy Market Highlights
The growing stringent regulation and standards for medical devices, and the increasing uncertainty about reimbursement in the US are threatening the growth of the market.
Request Free sample Copy at: https://www.marketresearchfuture.com/sample_request/3830
Increasing automation will enhance the capabilities of needle biopsy and it may substitute the needle biopsy procedures. Real time progression of cancers is also possible in needle biopsy which raises the level of threat it possesses to needle biopsy. The falling cost of products due to greater market fragmentation and the emergence of Chinese companies is expected to put additional pressures on prices.
In our estimates vacuum assisted needle biopsy will be the fastest growing segment. The increasing screening rates for cancers through the world will stimulate the market. Among the various cancers, breast cancer is expected to generate the largest use of needle biopsy. Needle Based Biopsy Guns is another lucrative strategy that is being pursued by many players. Core needle biopsy has a higher efficiency and detectability rate than fine needle aspiration biopsy. There is increasing bias to use core needle biopsy in combination with needle aspiration biopsy to achieve highest sensitivity and detectability. Thus, the two tests are complementary, and the effectiveness rate is highest with both tests are done together.
The global needle biopsy market is growing at a rate of 5.2 % and is expected show a similar trend during the forecast period. The needle biopsy market is chiefly driven by product development and the fall in prices of raw materials and components. The emergence of needle biopsy is estimated to pose the greatest threat to the biopsy needle market. Needle biopsy offers non-invasive diagnostic tests for detecting cancer as it used liquids such as blood, urine, saliva etc. to detect malignancy.
The increasing cases of cancers and growing usage of biopsy needles is driving the market. Companies should focus on improving the distribution efficiency so as to reduce the pressures on prices due to huge market fragmentation. Distributional agreements between large players and advanced products such as multilayer needles will be extremely beneficial.
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/needle-biopsy-market-3830
Global Needle biopsy Market Players:
Key players profiled in the report are Boston Scientific Corporation, Cook Medical, CareFusion Corporation, Hologic, Inc., and Cardinal Health, Inc., Medax, C. R. Bard, Inc., Möller Medical GmbH, Becton, Dickinson and Company, Hakko co. ltd., Kompass, Argon Medical Devices, Inc. and others.
Brows More Healthcare Related Research Reports
Image Guided Radiotherapy Market Size, Trends | Share Analysis, 2023
Central Pontine Myelinolysis Market Research Report- Forecast to 2023 | MRFR
EMEA Beauty Devices Market Size, Trends | Share Analysis, 2021
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team has supreme objectives to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Akash Anand,
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
0 notes
market-research-future · 4 years ago
Text
Needle Biopsy Industry Analysis, Key Players, Dynamics, Outlook To 2023
Needle Biopsy Market Share, Growth And Trends Analysis By Type (Fine-Needle Aspiration Biopsy, Core Needle Biopsy, Vacuum-Assisted Biopsy, Image-Guided Biopsy) By Utility (Disposable, Reusable), By Applications (Tumor, Infection, Inflammation, Others) - Global Forecast Till 2023
Needle Biopsy Market Segmentation:
The global needle biopsy market is segmented based on type and applications. Based on type, the market has been segmented as fine-needle aspiration biopsy, core needle biopsy, vacuum-assisted biopsy and image-guided biopsy. Based on the utility, the market has been segmented as disposable and reusable. Based on the applications, the Needle Biopsy Industry Analysis has been segmented as tumor, infection, inflammation and others.
Global Needle biopsy Market Players:
Key players profiled in the report are Boston Scientific Corporation, Cook Medical, CareFusion Corporation, Hologic, Inc., and Cardinal Health, Inc., Medax, C. R. Bard, Inc., Möller Medical GmbH, Becton, Dickinson and Company, Hakko co. ltd., Kompass, Argon Medical Devices, Inc. and others.
Needle Biopsy Market Highlights
The growing stringent regulation and standards for medical devices, and the increasing uncertainty about reimbursement in the US are threatening the growth of the market.
Request Free sample Copy at: https://www.marketresearchfuture.com/sample_request/3830
Increasing automation will enhance the capabilities of needle biopsy and it may substitute the needle biopsy procedures. Real time progression of cancers is also possible in needle biopsy which raises the level of threat it possesses to needle biopsy. The falling cost of products due to greater market fragmentation and the emergence of Chinese companies is expected to put additional pressures on prices.
In our estimates vacuum assisted needle biopsy will be the fastest growing segment. The increasing screening rates for cancers through the world will stimulate the market. Among the various cancers, breast cancer is expected to generate the largest use of needle biopsy. Needle Based Biopsy Guns is another lucrative strategy that is being pursued by many players. Core needle biopsy has a higher efficiency and detectability rate than fine needle aspiration biopsy. There is increasing bias to use core needle biopsy in combination with needle aspiration biopsy to achieve highest sensitivity and detectability. Thus, the two tests are complementary, and the effectiveness rate is highest with both tests are done together.
The global needle biopsy market is growing at a rate of 5.2 % and is expected show a similar trend during the forecast period. The needle biopsy market is chiefly driven by product development and the fall in prices of raw materials and components. The emergence of needle biopsy is estimated to pose the greatest threat to the biopsy needle market. Needle biopsy offers non-invasive diagnostic tests for detecting cancer as it used liquids such as blood, urine, saliva etc. to detect malignancy.
The increasing cases of cancers and growing usage of biopsy needles is driving the market. Companies should focus on improving the distribution efficiency so as to reduce the pressures on prices due to huge market fragmentation. Distributional agreements between large players and advanced products such as multilayer needles will be extremely beneficial.
Brows More Healthcare Related Research Reports
Image Guided Radiotherapy Market Size, Trends | Share Analysis, 2023
Central Pontine Myelinolysis Market Research Report- Forecast to 2023 | MRFR
EMEA Beauty Devices Market Size, Trends | Share Analysis, 2021
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team has supreme objectives to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Akash Anand,
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
0 notes